An Oregon study focused on rural residents found a promising method for eliminating hepatitis C, a common and potentially ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing.

Causes of cirrhosis include metabolic dysfunction-associated steatotic liver disease (MASLD), hepatitis, long-term alcohol use, and primary sclerosing cholangitis. According to the National ...